Evidence map›Paper›PMID 26471037›Full record

ArticleBMC genomics2015

Age and prior blood feeding of Anopheles gambiae influences their susceptibility and gene expression patterns to ivermectin-containing blood meals.

Jonathan A Seaman, Haoues Alout, Jacob I Meyers, Mark D Stenglein, Roch K Dabiré, Saul Lozano-Fuentes, Timothy A Burton, Wojtek S Kuklinski, William C Black, Brian D Foy

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
6.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Effect of IvermectinMalaria journal · 2023
    Article
  6. A globalBMC bioinformatics · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Ivermectin: a complimentary weapon against the spread of malaria?Expert review of anti-infective therapy · 2017
    Review
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Jonathan A SeamanDepartment of Microbiology, Immunology and Pathology, Arthropod-borne and Infectious Diseases Laboratory, Colorado State University 1692 Campus Delivery, Fort Collins, CO, 80525, USA. jon.a.seaman@gmail.com.
Haoues AloutDepartment of Microbiology, Immunology and Pathology, Arthropod-borne and Infectious Diseases Laboratory, Colorado State University 1692 Campus Delivery, Fort Collins, CO, 80525, USA. haoues.alout@gmail.com.
Jacob I MeyersDepartment of Microbiology, Immunology and Pathology, Arthropod-borne and Infectious Diseases Laboratory, Colorado State University 1692 Campus Delivery, Fort Collins, CO, 80525, USA. jacob.i.meyers@gmail.com.
Mark D StengleinDepartment of Microbiology, Immunology and Pathology, Arthropod-borne and Infectious Diseases Laboratory, Colorado State University 1692 Campus Delivery, Fort Collins, CO, 80525, USA. mark.stenglein@colostate.edu.
Roch K DabiréInstitute de Recherche en Sciences de la Santé (IRSS)/Centre Muraz, Direction Régionale de l'Ouest, 399 Ave de la Liberté, Bobo Dioulasso, Houet, 10400-000, Burkina Faso. dabire_roch@hotmail.com.
Saul Lozano-FuentesDepartment of Microbiology, Immunology and Pathology, Arthropod-borne and Infectious Diseases Laboratory, Colorado State University 1692 Campus Delivery, Fort Collins, CO, 80525, USA. lozano.saul@gmail.com.
Timothy A BurtonDepartment of Microbiology, Immunology and Pathology, Arthropod-borne and Infectious Diseases Laboratory, Colorado State University 1692 Campus Delivery, Fort Collins, CO, 80525, USA. timaburton@gmail.com.
Wojtek S KuklinskiDepartment of Microbiology, Immunology and Pathology, Arthropod-borne and Infectious Diseases Laboratory, Colorado State University 1692 Campus Delivery, Fort Collins, CO, 80525, USA. wojtek94@yahoo.com.
William C BlackDepartment of Microbiology, Immunology and Pathology, Arthropod-borne and Infectious Diseases Laboratory, Colorado State University 1692 Campus Delivery, Fort Collins, CO, 80525, USA. william.black@colostate.edu.
Brian D FoyDepartment of Microbiology, Immunology and Pathology, Arthropod-borne and Infectious Diseases Laboratory, Colorado State University 1692 Campus Delivery, Fort Collins, CO, 80525, USA. brian.foy@colostate.edu.
Colorado State University · USInstitut de Recherche en Sciences de la Santé · BF

Funding

Ivermectin for Malaria ControlR01AI094349 · NIAID · COLORADO STATE UNIVERSITY · PI FOY, BRIAN DAVID · 2012 to 2015
$2.0M
NIAID NIH HHS R01 AI094349
6 · The paper itself

Abstract

backgroundIvermectin has been proposed as a novel malaria transmission control tool based on its insecticidal properties and unique route of acquisition through human blood. To maximize ivermectin's effect and identify potential resistance/tolerance mechanisms, it is important to understand its effect on mosquito physiology and potential to shift mosquito population age-structure. We therefore investigated ivermectin susceptibility and gene expression changes in several age groups of female Anopheles gambiae mosquitoes.

methodsThe effect of aging on ivermectin susceptibility was analyzed in three age groups (2, 6, and 14-days) of colonized female Anopheles gambiaemosquitoes using standard survivorship assays. Gene expression patterns were then analyzed by transcriptome sequencing on an Illumina HiSeq 2500 platform. RT-qPCR was used to validate transcriptional changes and also to examine expression in a different, colonized strain and in wild mosquitoes, both of which blood fed naturally on an ivermectin-treated person.

resultsMosquitoes of different ages and blood meal history died at different frequencies after ingesting ivermectin. Mortality was lowest in 2-day old mosquitoes exposed on their first blood meal and highest in 6-day old mosquitoes exposed on their second blood meal. Twenty-four hours following ivermectin ingestion, 101 and 187 genes were differentially-expressed relative to control blood-fed, in 2 and 6-day groups, respectively. Transcription patterns of select genes were similar in membrane-fed, colonized, and naturally-fed wild vectors. Transcripts from several unexpected functional classes were highly up-regulated, including Niemann-Pick Type C (NPC) genes, peritrophic matrix-associated genes, and immune-response genes, and these exhibited different transcription patterns between age groups, which may explain the observed susceptibility differences. Niemann-Pick Type 2 genes were the most highly up-regulated transcripts after ivermectin ingestion (up to 160 fold) and comparing phylogeny to transcriptional patterns revealed that NPCs have rapidly evolved and separate members respond to either blood meals or to ivermectin.

conclusionWe present evidence of increased ivermectin susceptibility in older An. gambiae mosquitoes that had previously bloodfed. Differential expression analysis suggests complex midgut interactions resulting from ivermectin ingestion that likely involve blood meal digestion physiological responses, midgut microflora, and innate immune responses. Thus, the transcription of certain gene families is consistently affected by ivermectin ingestion, and may provide important clues to ivermectin's broad effects on malaria vectors. These findings contribute to the growing understanding of ivermectin's potential as a transmission control tool.

Indexed as

AnimalsAnophelesBloodFemaleGene Expression RegulationHumansIvermectinMalariaIvermectin

Identifiers

PMID26471037
PMCPMC4608139
OpenAlexW2101160092

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.